Study Set Content:
Odorless white crystals or crystalline powder with a slightly bitter taste
ACETYLSALICYLIC ACID
Disrupts the production of prostaglandins throughout the body by targeting
(COX-1 and COX-2
An antipyretic agent by interfering with the production of brain prostaglandins
E1
Inhibition of platelet aggregation interference with (blank) in platelets
thromboxane A2
Inhibition of platelet aggregation interference with thromboxane A2 in platelets, caused by
COX-1 inhibition
ASPIRIN for the treatment of mild to moderate pain
analgesic
ASPIRIN for the treatment of soft tissue and joint inflammation
Anti-inflammatory age
ASPIRIN uses
Antipyretic drug
Low doses salicylate s used for the prevention of
thrombosis
ASPIRIN
Stimulation of the
respiratory center
inhibition o
f citric acid cycle (carbohydrate metabolism
stimulation of (blank) metabolism
lipid metabolism
ASPIRIN TOXICITY of amino acid metabolism
inhibition
Toxicity: uncoupling o
oxidative phosphorylation
occur as the principal secondary consequences of salicylate intoxicatio
Respiratory alkalosis, metabolic acidosis, water and electrolyte loss
PHOSPHORIC ACID or
ORTHOPHOSPHORIC ACID
An acid a clear colorless liquid or transparent crystalline solid
PHOSPHORIC ACID
ORTHOPHOSPHORIC ACID is
Trihydroxidooxidoph
PHOSPHORIC ACID is
phosphorus
Phosphoric acid when concentrated it is
Corosive
